Arkolith/Insider Trading/SCTX/Form 4

Aghazadeh Behzad

Director, 10% OwnerScribe Therapeutics, Inc. (SCTX) · full profile →Form 4 · filed Jul 29, 2026
Net Buying
Open-Market Buys
$36.3M
Open-Market Sells
$0
Net Open-Market Flow
$36.3M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 28, 2026Buy(P)8K$18.25$144K3.1M
Jul 24, 2026Buy(P)2.3M$15.00$35.0M3.0M
Jul 24, 2026Buy(P)50K$22.31$1.1M3.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-26-003270) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML